Heteroaromatic sulfonamide prodrugs

Details for Australian Patent Application No. 2006319381 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Nubbemeyer, Reinhard; Wyrwa, Ralf

Agent Davies Collison Cave

Pub. Number AU-A-2006319381

PCT Pub. Number WO2007/062875

Priority 10 2005 057 421.1 30.11.05 DE

Filing date 27 November 2006

Wipo publication date 7 June 2007

International Classifications

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/5685 (2006.01)

A61P 15/02 (2006.01) Drugs for genital or sexual disorders

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

24 July 2008 PCT application entered the National Phase

  PCT publication WO2007/062875 Priority application(s): WO2007/062875

4 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006319382-Prodrugs of ER-beta-selective substances method for production thereof and pharmaceutical compositions comprising the same

2006319380-Sulfamoyl sulfonate prodrugs